Carotid Stenosis Clinical Trials

11 recruiting

Carotid Stenosis Trials at a Glance

14 actively recruiting trials for carotid stenosis are listed on ClinicalTrialsFinder across 6 cities in 12 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Basel, Bron, and Groningen. Lead sponsors running carotid stenosis studies include John Paul II Hospital, Krakow, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, and Charles University, Czech Republic.

Browse carotid stenosis trials by phase

Treatments under study

About Carotid Stenosis Clinical Trials

Looking for clinical trials for Carotid Stenosis? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Carotid Stenosis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Carotid Stenosis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting
Not Applicable

Remote Ischemic Conditioning Plus Stenting for Symptomatic Carotid Artery Stenosis

Carotid Stenosis
General Hospital of Shenyang Military Region300 enrolled1 locationNCT07412249
Recruiting
Not Applicable

Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control

Carotid Stenosis
Hospices Civils de Lyon77 enrolled1 locationNCT02748941
Recruiting
Not Applicable

Asymptomatic Carotid Stenosis and Mobility Function With Exercise Intervention

Mobility ImpairmentAsymptomatic Carotid Stenosis (50-69%)
VA Office of Research and Development50 enrolled1 locationNCT05436600
Recruiting

Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study

Carotid StenosisBrain StrokeCarotid Arteriosclerosis
Charles University, Czech Republic300 enrolled1 locationNCT07057297
Recruiting

Multicentric Study on Clopidogrel Resistance in DAPT for CAS (MULTI-RESCLOSA)

Carotid StenosisClopidogrel, Poor Metabolism of
IRCCS Policlinico S. Donato1,140 enrolled1 locationNCT05566301
Recruiting

Predictive Value of Neovascularization Within Asymptomatic Carotis Stenosis on CEUS

Carotid Stenosis
University Hospital, Basel, Switzerland240 enrolled1 locationNCT01732523
Recruiting

The Management of Asymptomatic Carotid Stenosis

Carotid StenosisCarotid Artery Diseases
Fondazione Policlinico Universitario Agostino Gemelli IRCCS500 enrolled1 locationNCT06882954
Recruiting
Phase 4

VTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb Revascularization

Cardiovascular DiseasesPeripheral Arterial DiseaseVenous Thormboembolism+1 more
Science Valley Research Institute100 enrolled1 locationNCT06873321
Recruiting

Selective Coronary Revascularization in Carotid Artery Disease Patients After Carotid Revascularization (SCORECAD Trial)

Coronary Artery DiseaseCarotid Stenosis
Pauls Stradins Clinical University Hospital300 enrolled1 locationNCT06546761
Recruiting
Phase 3

Carotid Artery Stenting During Endovascular Treatment of Acute Stroke

Stroke, IschemicStroke, AcuteCarotid Stenosis
University Medical Center Groningen600 enrolled1 locationNCT06511089
Recruiting
Not Applicable

Endovascular Acute Stroke Intervention - Tandem OCclusion Trial

Stroke, AcuteCarotid StenosisCarotid Artery Diseases
Centre hospitalier de l'Université de Montréal (CHUM)458 enrolled1 locationNCT04261478
Recruiting
Not Applicable

Carotid Revascularization With MicroNet Covered Stent Comparing Early Neurological Outcomes With Distal Versus Proximal EPS

Patients With Aterosclerotic Carotid StenosisSymptomatic Patients (Stenosis > 50%)Asymptomatic Patients (Stenosis ≥80%)
Meshalkin Research Institute of Pathology of Circulation366 enrolled1 locationNCT05257161
Recruiting

TRAnscranial Doppler CErebral Blood Flow and Cognitive IMPAIRment in Heart Failure

Heart FailureCognitive ImpairmentCarotid Stenosis
John Paul II Hospital, Krakow300 enrolled1 locationNCT05250349
Recruiting

Simultaneous Cardiac Surgery and Micronet-covered Stent Carotid Revascularization in High Perioperative Stroke Risk Patients

Myocardial InfarctionCoronary Artery DiseaseValvular Heart Disease+2 more
John Paul II Hospital, Krakow50 enrolled1 locationNCT04973579